Ubiquilin-2 liquid droplets: Are they promoting α-synuclein aggregation? (IMAGE)

Juntendo University Research Promotion Center

Ubiquilin-2 liquid droplets: Are they promoting α-synuclein aggregation?

Caption

The exact molecular mechanism via which α-synuclein, the main protein involved in Parkinson’s pathogenesis, aggregates is yet to be understood completely. In a recently published study, a team of researchers from Juntendo University tried to understand if ubiquilin-2 liquid droplets are catalyzing this aggregation mechanism. The findings from this study can lead to the development of new types of medicines for neurodegenerative diseases.

Credit

Professor Masaya Imoto and Professor Nobutaka Hattori from Juntendo University, Japan

Usage Restrictions

You are free to share and adapt the Infographic material but attribution is required, with a link to the news source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.